| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 61 buys and 0 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $34.9K | - | |
| VP | 171.4K | $31.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2019 | Broadrick Dale60 | 10% Owner | Buy | 2,088,852 | $0.03 | $67,587.58 | +3.2% | |
| Oct 28, 2019 | Broadrick Dale60 | 10% Owner | Buy | 409,713 | $0.13 | $51,593.22 | +1.1% | |
| Oct 17, 2019 | Broadrick Dale60 | 10% Owner | Buy | 3,798,400 | $0.17 | $643,004.02 | +4.1% | |
| Sep 9, 2019 | Alstodt Lance55 | EVP And Chief Strategy Officer | Buy | 20,000 | $0.26 | $5,220.00 | +15.6% | |
| Sep 6, 2019 | Weinreb Mark | CEO And Chairman Of The Board | Buy | 22,000 | $0.25 | $5,530.25 | +5.2% | |
| Sep 5, 2019 | Alstodt Lance55 | EVP And Chief Strategy Officer | Buy | 10,000 | $0.27 | $2,697.50 | +24.9% | |
| Sep 4, 2019 | Silva Francisco48 | VP Of Research And Development | Buy | 20,955 | $0.24 | $5,017.95 | +28.9% | |
| Aug 30, 2019 | Silva Francisco48 | VP Of Research And Development | Buy | 18,000 | $0.28 | $4,989.50 | +29.5% | |
| Aug 29, 2019 | Tonna Paul Jude | Director | Buy | 17,850 | $0.28 | $4,917.68 | +16.8% | |
| Aug 29, 2019 | Weinreb Mark | CEO And Chairman Of The Board | Buy | 10,000 | $0.26 | $2,607.50 | +2.8% |